ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers	With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer	Recruiting	Phase 1	2025-07-25		NCT06513624

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
EDDC (Experimental Drug Development Centre), A*STAR Research Entities	3
National University Hospital, Singapore	120

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National Cancer Centre Singapore	Singapore	Singapore	1
National University Hospital	Singapore	Singapore	46

Clinical trials